Notice: Educational. Affiliate links. Not medical advice.
How starting and maintaining a GLP-1 treatment via compliant telehealth works in 2026.
Before applying, dedicate 30-60 minutes to evaluate 2-3 programs. Verify they have: clear 503A pharmacy disclosure, licensed providers in your state, transparent pricing (no surprises in month 3+), and a clean regulatory record (no recent FDA warning letters).
Time: 30-60 min · Cost: $0
Complete a 5-15 minute medical questionnaire. It asks about: weight, height, BMI, comorbidities (high blood pressure, diabetes, sleep apnea, etc.), family history of thyroid cancer, pregnancy, current medications, and allergies. Honesty here is critical — if you lie, you put your health at risk.
Time: 5-15 min · Cost: $0 - $99 depending on program
A physician (MD/DO), nurse practitioner (NP), or physician assistant (PA) licensed in your state reviews your case. Some platforms do video calls (ideal), others asynchronous review of the questionnaire. Here they may ask for labs (typically free or $30-$80 add-on), particularly for diabetes, thyroid function, and liver function.
Time: 24-72 hours · Cost: included or $50-$150
If you qualify, the provider writes a prescription for compounded semaglutide or tirzepatide. The prescription goes to a licensed 503A pharmacy (not an unknown "compounder facility" — verify the name and license number). If you do NOT qualify, serious programs tell you — that's a good sign.
Time: 24-48 hours after consultation
The compounded pharmacy prepares your medication under patient-specific prescription, labels it with your name, and ships it with cold chain (refrigerated) to your home. Includes: vials or auto-injector pen, syringes, alcohol swabs, sharps container, and instructions for use. First shipment arrives in 3-7 business days.
Time: 3-7 business days · Cost: $179-$499/month depending on medication and dose
Once a week, you inject yourself subcutaneously (typically abdomen or thigh). Takes 30 seconds. The first 2-4 weeks you use a low dose to minimize nausea. Every 4 weeks the dose is increased until reaching the maintenance dose (typically week 16-20).
Time: 30 seconds/week
Every 30 days the provider reviews your progress (weight, side effects, dose) and adjusts if necessary. Most serious programs include messaging for questions. If you experience strong side effects, you contact the provider immediately — do NOT adjust dose on your own.
Time: ~15-30 min/month
Month 1 — Adaptation
Moderate nausea common. Notable appetite reduction. 2-5% loss. If nausea is severe, contact the provider.
Months 2-3 — Stabilization
Side effects diminish. Establishment of new eating routine. Cumulative loss 5-10%.
Months 4-6 — Sustained progress
Average loss 12-18%. Some brief plateaus — normal. Ideal time to incorporate strength training.
Months 7-12 — Maximization
Cumulative loss approaching 18-24% (tirzepatide). Decision: continue to maintenance or evaluate alternatives (including Retatrutide when approved).
Year 2+ — Maintenance
If you decide to continue, dose typically maintains or slightly reduces. If you stop without maintenance protocol, high risk of ~67% regain.
Apply with one of the programs we recommend as a bridge to the Retatrutide launch.
See recommended programs →